PDLI News and Press, PDL BioPharma Inc.

Price matters most to making money in the market. Celebrating 20 years, Stock Traders Daily provides the tools that help you develop investment strategies, and this is a good example. When we couple this with our market based analysis, the probabilities of going with the flow increases, and t...

Sio Gene Therapies (SIOX) +42% on positive AXO-AAV-GM1 data in nerve cell disorder.Good Times Restaurants (GTIM) +27% on Q4 results.Tilray (TLRY) +27% as company to combine with Aphria to create largest global cannabis company.DAVIDsTEA (DTEA) +25% on Q3 results.NeuBa...

PDL BioPharma ([[PDLI]] +5.2%) has entered into a Capital Provision Agreement with Epps Investments LLC. Under the terms, Epps to pay PDL ~$51.39M no later than December 31, 2020, in exchange for 100% of the payments received by PDL on or after the date of the Agreement pursuant to the settle...

PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat RENO, Nev. , Dec. 14, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDL...

Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...

PDL BioPharma (PDLI) -3.9% PM, formally notified The Nasdaq of its intent to delist its common stock from the Nasdaq on or about Dec.28, 2020 and suspend trading prior to the Dec.31 market open.PDL intends to file a certificate of dissolution with the Delaware Secretary of...

PDL Announces Timeline for Voluntarily Delisting from Nasdaq INCLINE VILLAGE, Nev. , Dec. 8, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has formally notified The Nasdaq Stock Market, Inc. of its intent to...

PDLI is liquidating, it should delist from the NASDAQ on December 31, 2020. Patient investors can ultimately expect a return of approximately 40% based on net assets. The Glumetza royalties may be undervalued today based on arguably a punitive discount rate, creating closer to 60%...

Image source: The Motley Fool. PDL Biopharma Inc (NASDAQ: PDLI) Q3 2020 Earnings Call Nov 11, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: PDL Biopharma Inc (PDLI) Q3 2020 Earnings Call Transcript

PDL BioPharma, Inc. (PDLI) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Dominique Monnet – President and Chief Executive Officer Edward Imbrogno – Vice President and Chief Financial Officer Conferenc...